nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 05, v.47 50-56
剂量跌落环联合虚拟限量环在鼻咽癌同步推量调强放疗中的应用研究
基金项目(Foundation): 荆门市一般科技计划项目(2023YFYB003)
邮箱(Email): jmeylrj@163.com;
DOI: 10.19745/j.1003-8868.2026074
发布时间: 2026-05-15
出版时间: 2026-05-15
移动端阅读
摘要:

目的:探讨剂量跌落环(dose fall-off ring,DFOR)联合虚拟限量环(virtual dose-limiting ring,VDLR)在优化鼻咽癌同步推量调强放疗(simultaneous integrated boost intensity-modulated radiotherapy,SIB-IMRT)计划剂量分布中的应用价值。方法:回顾性选取某院20例接受鼻咽癌SIB-IMRT的初治患者,基于Monaco计划系统对每位患者设计仅使用VDLR限制靶区外部剂量分布的SIB-IMRT1计划和使用DFOR联合VDLR限制靶区外部剂量分布的SIBIMRT2计划,评估2种SIB-IMRT计划计划靶区(planning target volume,PTV)、危及器官(organs at risk,OAR)的剂量学参数以及治疗参数(子野个数、机器跳数、出束时间)的差异。采用SPSS 26.0软件进行统计学分析。结果:2种SIB-IMRT计划剂量学参数均满足临床治疗要求。SIB-IMRT,计划的PTVp、PTVn和PTV2的D2%、Dmean和均匀性指数,PTVp1的D2%、Dmean和D98%,PTVn1的D2%和均匀性指数,PTV6 006-6 996的V6 006-6 996,6 600及PTV2-6 006的V2-6 006,6 006劣于SIB-IMRT2计划,差异有统计学意义(P<0.05);SIB-IMRT1计划PTVn1的D98%和适形度指数优于SIB-IMRT2计划,差异有统计学意义(P<0.05);SIB-IMRT1计划腮腺、口腔和喉的Dmean以及body-PTV2的Vbody-2,4 000。劣于SIB-IMRT2计划,差异有统计学意义(P<0.05)。SIB-IMRT1计划的子野个数和机器跳数多于SIB-IMRT2计划,差异有统计学意义(P<0.05);2种计划出束时间比较差异无统计学意义(P>0.05)。由剂量-体积直方图可知,与SIB-IMRT1计划相比,SIB-IMRT2计划部分靶区及OAR的剂量学参数和body-PTV2的剂量学参数具有明显优势。结论:与单纯依赖VDLR的SIBIMRT1计划相比,在出束时间未发生显著变化的前提下,联合使用DFOR与VDLR的SIB-IMRT2计划不仅优化了部分靶区剂量学参数,同时在部分OAR和body-PTV2的保护方面也展现出更优越的剂量学表现。

Abstract:

Objective To analyze the application value of combining a dose fall-off ring(DFOR) with a virtual doselimiting ring(VDLR) in optimizing the dose distribution of simultaneous integrated boost intensity-modulated radiotherapy(SIB-IMRT) plans for nasopharyngeal carcinoma(NPC). Methods Twenty newly diagnosed NPC patients treated at some hospital with SIB-IMRT were selected. For each patient, two SIB-IMRT plans were designed based on Monaco planning system: SIB-IMRT1 which utilized VDLR alone to restrict dose distribution outside the target volumes and SIB-IMRT2 which combined DFOR with VDLR to restrict dose distribution outside the target volumes. The two types of SIB-IMRT plans were compared in terms of dosimetric parameters for the planning target volume(PTV) and organs at risk(OAR), as well as treatment delivery parameters such as number of segments, monitor units(MU) and delivery time. Statistical analysis was carried out with SPSS 26.0 software. Results The dosimetric parameters of both the SIB-IMRT plans met the requirements for clinical treatment. The SIB-IMRT1 plan had the D2%, Dmean and homogeneity index(HI) of PTVp, PTVn and PTV2, D2%, Dmean and D98% of PTVp1, D2% and HI of PTVn1, V6 006-6 996, 6 600 of PTV6 006-6 996 and V2-6 006, 6 006 of PTV2-6 006 inferior to those of the SIB-IMRT2 plan, with the differences being statistically significant(P < 0.05); the D98% and conformity index(CI) of PTVn1 in the SIB-IMRT1 plan were slightly better than those in the SIB-IMRT2 plan, with the differences being statistically significant(P < 0.05); the SIB-IMRT1 plan had the Dmean of the parotid gland, oral cavity, and larynx and Vbody-2,4 000 of body-PTV2 inferior to those of the SIB-IMRT2 plan, with the differences being statistically significant(P < 0.05). The SIB-IMRT1 plan had the numbers of segments and MU higher than those of the SIB-IMRT2 plan, with the differences being statistically significant(P < 0.05); the two types of plans had no significant differences in the delivery time(P > 0.05). The dose-volume histogram showed that the SIB-IMRT2 plan behaved better than the SIB-IMRT1 plan in some dosimetric parameters of PTVs, OARs and body-PTV2. Conclusion Compared to the SIB-IMRT1 relying solely on VDLR, the SIB-IMRT2 plan combining DFOR and VDLR without significantly altering the beam delivery time optimizes some PTV dosimetric parameters, and demonstrates superior dosimetric performance in sparing some OARs and bodyPTV2.

参考文献

[1]廖恺,田允鸿,郑荣辉,等.早期鼻咽癌调强放疗设置颈前后部限量环减少头颈淋巴水肿的剂量学研究[J].实用医学杂志,2024,40(12):1 659-1 664.

[2]曹振梅,孙涛,雷伟杰,等.鼻咽癌固定野和旋转调强放疗计划海马剂量差异比较[J].中华肿瘤防治杂志,2022,29(20):1 484-1 494.

[3]陈颖,刘茹佳,钟志鹏,等.基于外轮廓的虚拟限量环在宫颈癌固定野调强放疗中的应用[J].医疗卫生装备,2021,42(9):36-40.

[4]王颢钧,肖倍倍,马骏,等. EB病毒与鼻咽癌研究进展[J].中国科学:生命科学,2024,54(12):2 330-2 343.

[5]殷欢,薛芬,何霞云,等.早期鼻咽癌调强适形放射治疗的长期疗效及不良反应[J].复旦学报(医学版),2022,49(4):542-547.

[6]袁东杰,李靖,李艳峰,等.紫杉醇+顺铂同步放化疗与序贯放化疗治疗局部晚期鼻咽癌患者的疗效及安全性[J].癌症进展,2025,23(9):1 008-1 011.

[7]梁锋攀.鼻咽癌放射治疗的相关研究进展[J].癌症进展,2021,19(10):988-990,1 010.

[8]刘花,廖鹏飞,陈维斌,等.常规分割后缩野同步放化疗治疗鼻咽癌患者的临床疗效及对预后的影响[J].癌症进展,2025,23(7):829-832.

[9]MOHAN R. Intensity-modulated radiation therapy-you can have your cake and eat it too![J]. Med Phys,2023,50(S1):74-79.

[10]VARMAGHANI M,AMIRI M,EBRAHIMPOUR H,et al.The cost effectiveness of intensity-modulated radiation therapy and three-dimensional conformal radiotherapy in the treatment of head and neck cancers[J]. Radiat Oncol,2023,18(1):138.

[11]贺先桃,谭军文,李钢,等.叶片运动限制参数对容积旋转调强放疗的影响[J].医疗卫生装备,2020,41(11):40-45.

[12]YILDIRIM H C,KUPIK G E,MUSTAFAYEV T Z,et al. A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population:Turkish Society for Radiation Oncology Head and Neck Cancer Group Study(TROD 01-001)[J]. Head Neck,2023,45(5):1 194-1 205.

[13]刘彬,陈姿,胡智慧,等.同步推量调强放疗对晚期鼻咽癌患者生存质量的影响[J].中国医学物理学杂志,2025,42(5):577-580.

[14]杨利利,胡永强,杨海林,等.同步推量调强放疗治疗鼻咽癌的效果及预后观察[J].实用癌症杂志,2021,36(11):1 890-1 893.

[15]卢江岳,张建鑫,葛晓峰.鼻咽癌同步推量同步放化疗与常规分割后缩野同步放化疗的疗效及毒性反应对比分析[J].实用肿瘤学杂志,2020,34(5):440-445.

[16]陈颖,刘茹佳,钟志鹏,等.基于Monaco计划系统的3种混合推量计划设计方法在鼻咽癌放疗中的差异比较[J].医疗卫生装备,2023,44(11):50-55.

[17]HAWKINS P G,LEE J Y,MAO Y,et al. Sparing all salivary glands with IMRT for head and neck cancer:longitudinal study of patient-reported xerostomia and head-and-neck quality of life[J]. Radiother Oncol,2018,126(1):68-74.

[18]SANGUINETI G,ADAPALA P,ENDRES E J,et al. Dosimetric predictors of laryngeal edema[J]. Int J Radiat Oncol,2007,68(3):741-749.

[19]SMITH B G,LEWIN J S. Lymphedema management in head and neck cancer[J]. Curr Opin Otolaryngol Head Neck Surg,2010,18(3):153-158.

[20]JACKSON L K,RIDNER S H,DENG J,et al. Internal lymphedema correlates with subjective and objective measures of dysphagia in head and neck cancer patients[J]. J Palliat Med,2016,19(9):949-956.

基本信息:

DOI:10.19745/j.1003-8868.2026074

中图分类号:R739.63

引用信息:

[1]陈颖,刘茹佳,钟志鹏,等.剂量跌落环联合虚拟限量环在鼻咽癌同步推量调强放疗中的应用研究[J].医疗卫生装备,2026,47(05):50-56.DOI:10.19745/j.1003-8868.2026074.

基金信息:

荆门市一般科技计划项目(2023YFYB003)

发布时间:

2026-05-15

出版时间:

2026-05-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文